[96a5a0]: / output / allTrials / identified / NCT00937560_identified.json

Download this file

301 lines (301 with data), 11.7 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
{
"info": {
"nct_id": "NCT00937560",
"official_title": "A Single-arm Phase II Clinical Study Investigating the Addition of Bevacizumab to Carboplatin and Weekly Paclitaxel as First-line Treatment in Patients With Epithelial Ovarian Cancer",
"inclusion_criteria": "Healthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
"exclusion_criteria": "",
"miscellaneous_criteria": "Inclusion Criteria\n\n* Female patients, ≥ 18 years of age.\n* Epithelial ovarian, fallopian tube, or primary peritoneal cancer.\n* Initial surgery, but no chemotherapy or radiotherapy.\n* Eastern Cooperative Oncology Group (ECOG) performance status of 0-2.\n\nExclusion Criteria\n\n* Non-epithelial tumors.\n* Ovarian tumors with low malignant potential.\n* Previous systemic anti-cancer therapy for ovarian cancer.\n* History or evidence of synchronous primary endometrial cancer.\n* Current or recent daily treatment with aspirin (> 325mg/day) or with full dose anticoagulant or thrombolytic agents for therapeutic purposes."
},
"inclusion_lines": [
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be FEMALE",
"criterions": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "female"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [],
"miscellaneous_lines": [
{
"line": "* Female patients, ≥ 18 years of age.",
"criterions": [
{
"exact_snippets": "Female patients",
"criterion": "gender",
"requirements": [
{
"requirement_type": "value",
"expected_value": "female"
}
]
},
{
"exact_snippets": "≥ 18 years of age",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "* Epithelial ovarian, fallopian tube, or primary peritoneal cancer.",
"criterions": [
{
"exact_snippets": "Epithelial ovarian",
"criterion": "epithelial ovarian cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "fallopian tube",
"criterion": "fallopian tube cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "primary peritoneal cancer",
"criterion": "primary peritoneal cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Initial surgery, but no chemotherapy or radiotherapy.",
"criterions": [
{
"exact_snippets": "Initial surgery",
"criterion": "surgery",
"requirements": [
{
"requirement_type": "type",
"expected_value": "initial"
}
]
},
{
"exact_snippets": "no chemotherapy",
"criterion": "chemotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "no ... radiotherapy",
"criterion": "radiotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Eastern Cooperative Oncology Group (ECOG) performance status of 0-2.",
"criterions": [
{
"exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status of 0-2.",
"criterion": "ECOG performance status",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 2,
"unit": "N/A"
}
]
}
}
]
}
]
},
{
"line": "* Non-epithelial tumors.",
"criterions": [
{
"exact_snippets": "Non-epithelial tumors.",
"criterion": "tumor type",
"requirements": [
{
"requirement_type": "type",
"expected_value": "non-epithelial"
}
]
}
]
},
{
"line": "* Ovarian tumors with low malignant potential.",
"criterions": [
{
"exact_snippets": "Ovarian tumors",
"criterion": "ovarian tumors",
"requirements": [
{
"requirement_type": "malignant potential",
"expected_value": "low"
}
]
}
]
},
{
"line": "* Previous systemic anti-cancer therapy for ovarian cancer.",
"criterions": [
{
"exact_snippets": "Previous systemic anti-cancer therapy for ovarian cancer.",
"criterion": "systemic anti-cancer therapy",
"requirements": [
{
"requirement_type": "previous treatment",
"expected_value": true
}
]
}
]
},
{
"line": "* History or evidence of synchronous primary endometrial cancer.",
"criterions": [
{
"exact_snippets": "History or evidence of synchronous primary endometrial cancer.",
"criterion": "synchronous primary endometrial cancer",
"requirements": [
{
"requirement_type": "history or evidence",
"expected_value": true
}
]
}
]
},
{
"line": "* Current or recent daily treatment with aspirin (> 325mg/day) or with full dose anticoagulant or thrombolytic agents for therapeutic purposes.",
"criterions": [
{
"exact_snippets": "Current or recent daily treatment with aspirin (> 325mg/day)",
"criterion": "aspirin treatment",
"requirements": [
{
"requirement_type": "dosage",
"expected_value": {
"operator": ">",
"value": 325,
"unit": "mg/day"
}
}
]
},
{
"exact_snippets": "Current or recent daily treatment ... with full dose anticoagulant",
"criterion": "anticoagulant treatment",
"requirements": [
{
"requirement_type": "dosage",
"expected_value": "full dose"
}
]
},
{
"exact_snippets": "Current or recent daily treatment ... with ... thrombolytic agents for therapeutic purposes",
"criterion": "thrombolytic agent treatment",
"requirements": [
{
"requirement_type": "purpose",
"expected_value": "therapeutic"
}
]
}
]
}
],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": [
{
"line": "Inclusion Criteria",
"criterions": []
},
{
"line": "Exclusion Criteria",
"criterions": []
}
]
}